Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. [electronic resource]
Producer: 20090908Description: F729-39 p. digitalISSN:- 1522-1466
- Acetylcysteine -- pharmacology
- Amides -- pharmacology
- Animals
- Antioxidants -- pharmacology
- Biphenyl Compounds -- pharmacology
- Cell Line
- Cell Transdifferentiation
- Diabetes Mellitus, Experimental -- complications
- Diabetes Mellitus, Type 1 -- complications
- Diabetes Mellitus, Type 2 -- complications
- Diabetic Nephropathies -- enzymology
- Enzyme Inhibitors -- pharmacology
- Extracellular Matrix Proteins -- genetics
- Fibrosis
- Gene Expression Regulation
- Histone Deacetylase 2
- Histone Deacetylase Inhibitors
- Histone Deacetylases -- genetics
- Humans
- Hydroxamic Acids -- pharmacology
- Kidney -- drug effects
- Male
- Mice
- RNA Interference
- RNA, Messenger -- metabolism
- Rats
- Rats, Sprague-Dawley
- Reactive Oxygen Species -- metabolism
- Recombinant Proteins -- metabolism
- Repressor Proteins -- antagonists & inhibitors
- Transforming Growth Factor beta1 -- metabolism
- Valproic Acid -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.